Association of Serum Irisin Concentrations with the Presence and Severity of Obstructive Sleep Apnea Syndrome

Yanli Li,Xueqin Li,Dejun Sun,Shaoxi Cai
DOI: https://doi.org/10.1002/jcla.22077
IF: 3.124
2016-01-01
Journal of Clinical Laboratory Analysis
Abstract:OBJECTIVE:Obesity is involved in the pathogenesis of obstructive sleep apnea syndrome (OSAS). Irisin, a recently discovered myokine, protects the mice from obesity. This study aims to determine the association of serum irisin concentrations with the presence and severity of OSAS.METHODS:This cross-sectional investigation was performed in 165 male OSAS patients and 98 healthy male subjects. Serum irisin concentrations were assessed using an enzyme-linked immunosorbent assay kit.RESULTS:The serum irisin concentrations of OSAS patients significantly decreased compared with the healthy controls (P<.001). Multivariable logistic regression analysis indicated that serum irisin concentrations were an independent determinant of OSAS (OR .971, 95% CI .960 to .981; P<.001). Serum irisin concentrations were significantly reduced among patients with severe OSAS compared with patients with mild and moderate OSAS (P<.001 and P=.010, respectively). Spearman correlation analysis revealed that serum irisin concentrations were inversely correlated with OSAS severity (r=-.327, P<.001).CONCLUSION:Decreased serum irisin concentrations are associated with the presence and severity of OSAS.
What problem does this paper attempt to address?